Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study

(2011) S. Guglielmetti et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Double-Blind Randomized Controlled Trial of Rifaximin for Persistent Symptoms in Patients with Celiac Disease

(2011) Matthew S. Chang et al.   DIGESTIVE DISEASES AND SCIENCES

Double-blind, Placebo-controlled Antibiotic Treatment Study of Small Intestinal Bacterial Overgrowth in Children With Chronic Abdominal Pain

(2011) Brynie Slome Collins et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

(2010) M. Furnari et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Abnormal Breath Testing in IBS: A Meta-Analysis

(2010) Eric D. Shah et al.   DIGESTIVE DISEASES AND SCIENCES

Small intestinal bacterial overgrowth syndrome

(2010) Jan Bures   WORLD JOURNAL OF GASTROENTEROLOGY

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

(2009) Alexander C. Ford et al.   Clinical Gastroenterology and Hepatology

Review article: probiotics and prebiotics in irritable bowel syndrome

(2008) R. SPILLER   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy

(2008) Ernesto C. Lauritano et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY